fashion -WSS

fashion

author：Wikipedia 2025-09-29 16:34:14 - browse：2281

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： First transplant of an entire human eye performed

entertainment

WSS

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

France's anti

France's anti

Grail's uphill battle for Medicare to cover its cancer screening test

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

explore

fashion

Wikipedia

Activists slam private health insurers over coverage restrictions

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Cancer drug shortages should be causing more outrage

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Bright Health sells Medicare Advantage business to Molina

Weight loss drugs should be covered by insurers, AMA says

DIEP, the 'gold standard' of breast reconstruction, is under threat

Study suggests Covid rebound is far more common with Paxlovid than without

hotspot

Cancer diagnosis changes perspective doctor, former hospital CEO

Digital health funding stays low as a new reality sets in

Cancer diagnosis changes perspective doctor, former hospital CEO

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Britney Spears to release memoir, 'The Woman In Me,' later this year

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

hotspot

entertainment

explore

hotspot